Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mouth Neoplasms × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 672 Precursor Cell Lymphoblastic Leukemia-Lymphoma 144 Recurrence 107 Neoplasms, Plasma Cell 98 Leukemia 78 Lymphoma 74 Neoplasms 70 Vomiting 47 Burkitt Lymphoma 44 Lymphoma, Non-Hodgkin 41 Immunoglobulin Light-chain Amyloidosis 41 Lymphoma, Large B-Cell, Diffuse 33 Lymphoma, Mantle-Cell 31 Nausea 30 Prostatic Neoplasms 29 Lymphoma, Follicular 27 Waldenstrom Macroglobulinemia 26 Neoplasm Metastasis 23 Breast Neoplasms 23 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia, Myeloid, Acute 22 Hodgkin Disease 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 19 Amyloidosis 16 Lymphoma, Extranodal NK-T-Cell 14 Lymphoma, B-Cell, Marginal Zone 14 Leukemia, Biphenotypic, Acute 14 Colorectal Neoplasms 13

Interventions

Cisplatin 25 Magnetic Resonance Spectroscopy 19 Radiotherapy 16 pembrolizumab 15 Specimen Handling 15 Cetuximab 15 Radiotherapy, Intensity-Modulated 12 Biopsy 11 Carboplatin 10 Radiation 9 Paclitaxel 9 Fluorouracil 9 Platinum 8 1,2-diaminocyclohexaneplatinum II citrate 8 Surveys and Questionnaires 7 Surgical Procedures, Operative 7 Drug Therapy 7 X-Rays 6 Standard of Care 6 Celecoxib 6 Taxes 5 Sentinel Lymph Node Biopsy 5 Observation 5 Nivolumab 5 Metformin 4 Interviews as Topic 4 Immunohistochemistry 4 Fluorodeoxyglucose F18 4 Docetaxel 4 Chemoradiotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

National Health Research Institutes, Taiwan

Phase 2/3 Terminated

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡